Thursday, June 18, 2020

June 18, 2020 at 05:28PM Guidance for Industry for the Submission of Chemistry, Manufacturing, and Controls Information for a Therapeutic Recombinant DNA-Derived Product or a Monoclonal Antibody Product for In Vivo Use

This is the Guidance for Industry for the Submission of Chemistry, Manufacturing, and Controls Information for a Therapeutic Recombinant DNA-Derived Product or a Monoclonal Antibody Product for In Vivo Use.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hFgFG2

No comments:

Post a Comment